Eaton Vance Management Ultragenyx Pharmaceutical Inc. Transaction History

Eaton Vance Management

  • $67.5 Billion
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$45.8 - $85.4 $586,377 - $1.09 Million
-12,803 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$62.2 - $84.4 $752,806 - $1.02 Million
12,103 Added 1729.0%
12,803 $930,000
Q2 2021

Aug 16, 2021
SELL
$92.19 - $115.71 $6,914 - $8,678
-75 Reduced 9.68%
700 $67,000
Q1 2021

May 17, 2021
BUY
$106.9 - $167.73 $82,847 - $129,990
775 New
775 $88,000

Others Institutions Holding RARE

# of Institutions
324
Shares Held
85.5M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.01B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email